Publications

5803 Results

Improved overall survival trends of men with newly diagnosed M1 prostate cancer: a SWOG phase III trial experience (S8494, S8894 & S9346)

Authors
C Tangen;M Hussain;C Higano;M Eisenberger;E Small;G Wilding;B Donnelly;PM Venner;P Schellhammer;ED Crawford;N Vogelzang;I Powell;IM Thompson
Journal / Conference
Journal of Urology 188(4):1164-1169;
Year
2012
Research Committee(s)
Genitourinary
PMID
PMID22921015
PMC
PMC3481164
Study Number(s)
SWOG-8494 (INT-0036), SWOG-8894 (INT-0105) (EST-2889), SWOG-9346

A phase 2 study of vorinostat for treatment of relapsed or refractory hodgkin lymphoma: SWOG S0517

Authors
M Kirschbaum;B Goldman;J Zain;JR Cook;L Rimsza;S Forman;R Fisher
Journal / Conference
Leukemia & Lymphoma 53(2):259-262
Year
2012
Research Committee(s)
Lymphoma
PMID
PMID21823829
PMC
PMC3477846
Study Number(s)
S0517

Phase II trial of simple oral therapy with capecitabine and cyclophosphamide in patients with metastatic breast cancer: SWOG S0430 [PMID22267853]

Authors
A Schott;W Barlow;K Albain;H Chew;J Wade;K Lanier;D Lew;DF Hayes;JR Gralow;RB Livingston;G Hortobagyi
Journal / Conference
The Oncologist 17(2):179-187;
Year
2012
Research Committee(s)
Breast
PMID
PMID22267853
PMC
PMC3286166
Study Number(s)
S0430

Finasteride reduces the risk of incident symptomatic benign prostatic hyperplasia

Authors
JK Parsons;JM Schenk;KB Arnold;K Messer;K Messer;C Till;IM Thompson;A Kristal
Journal / Conference
European Urology, 61(6):1263-1270;
Year
2012
Research Committee(s)
Cancer Control
PMID
PMID22459892
PMC
PMC4059403
Study Number(s)
SWOG-9217

Health-related quality of life findings for the Prostate Cancer Prevention Trial

Authors
CM Moinpour;A Darke;G Donaldson;D Cespedes;J Smith;C Johnson;P Ganz;D Patrick;JE Ware;SA Shumaker;FL Meyskens;IM Thompson
Journal / Conference
Journal of the National Cancer Institute 104(18):1373-1385;
Year
2012
Research Committee(s)
Cancer Control
PMID
PMID22972968
PMC
PMC3529595
Study Number(s)
SWOG-9217

Evaluation of selenium supplementation on the prevention of bladder cancer in SWOG-coordinated SELECT

Authors
Y Lotan;P Goodman;R Youssef;R Svatek;S Shariat;C Tangen;IM Thompson;E Klein
Journal / Conference
Journal of Urology 187(6):2005-2010;
Year
2012
Research Committee(s)
Prevention, Screening, and and Surveillance
PMID
PMID22498220
PMC
PMC4294531
Study Number(s)
S0000

Prioritization in comparative effectiveness research: the CANCERGEN experience in cancer genomics

Authors
R Thariani;W Wong;J Carlson;L Garrison;SD Ramsey;P Deverka;L Esmail;S Rangarao;C Hoban;L Baker;D Veenstra
Journal / Conference
Medical Care 50(5):388-393;
Year
2012
Research Committee(s)
Breast
PMID
PMID22274803
PMC
PMC3469160
Study Number(s)
S1007

Cetuximab plus cisplatin, irinotecan, and thoracic radiotherapy as definitive treatment for locally advanced, unresectable esophageal cancer: a phase II study of the SWOG (S0414)

Authors
M Tomblyn;B Goldman;C Thomas;J Benedetti;H Lenz;V Mehta;T Beeker;P Gold;J Abbruzzese;C Blanke
Journal / Conference
Journal of Thoracic Oncology 7(5):906-992;
Year
2012
Research Committee(s)
Gastrointestinal
PMID
PMID22481235
PMC
PMC3382003
Study Number(s)
S0414

A phase II trial of doxorubicin and gemcitabine in renal cell carcinoma with sarcomatoid features: ECOG 8802

Authors
NB Haas;X Lin;J Manola;M Pins;G Liu;D Mcdermott;D Nanus;E Heath;G Wilding;J Dutcher
Journal / Conference
Medical Oncology 29(2):761-767
Year
2012
Research Committee(s)
Genitourinary
PMID
PMID21298497
PMC
PMC3566570
Study Number(s)
CTSU/E8802

Phase I and randomized phase II trial of gemcitabine, erlotinib, and IMC-A12 (cixutumumab) versus gemcitabine plus erlotinib as first line treatment in patients with metastatic pancreatic cancer (SWOG-0727)

Authors
PA Philip;B Goldman;R Ramanathan;HJ Lenz;A Lowy;RP Whitehead;S Iqbal;R Gaur;J Benedetti;CD Blanke
Journal / Conference
Journal of Clinical Oncology 30(suppl 4; abstr 198); ASCO 2012 GI Cancers Symposium, poster;
Year
2012
Research Committee(s)
Gastrointestinal
Study Number(s)
S0727